STARTUP/TECHNOLOGY RPG Life Sciences Arm To Acquire Raghava Life Sciences API For ₹135 Cr

RPG Life Sciences Ltd’s wholly owned subsidiary RPG Active Pharma Ltd (RPGAP) has entered into a Business Transfer Agreement to acquire the Active Pharmaceutical Ingredients (API) and intermediates business of Raghava Life Sciences Pvt Ltd for ₹135 crore. The business will be acquired on a going-concern basis through a slump sale. The transaction is part […]

CW Bureau · Sep 3, 2026

GENERAL Sun Pharmaceutical Agrees To MFN Pricing For US Medicaid Programmes

Sun Pharmaceutical Industries has joined several pharmaceutical companies in announcing agreements with the US government aimed at prioritising access to affordable medicines for millions of American patients. Under its agreement, Sun Pharma will extend Most Favoured Nation (MFN) pricing to state Medicaid programmes. The company has also committed to MFN pricing for future innovative medicine […]

CW Bureau · Sep 1, 2026

GENERAL Biocon Biologics Secures Japan Govt Approval For Pegfilgrastim Biosimilar

Biocon Biologics Ltd, a wholly owned subsidiary of Biocon Ltd., has received marketing approval from Japan’s Ministry of Health, Labour and Welfare (MHLW) for its pegfilgrastim biosimilar, strengthening the company’s biosimilars portfolio in the Japanese market. The product is a biosimilar to Neulasta, a pegfilgrastim-based medicine used to reduce the risk of infection associated with […]

CW Bureau · Aug 25, 2026

GENERAL Piramal Pharma Acquires Additional 40.67% Stake In Yapan Bio For ₹76 Cr

Piramal Pharma Ltd has completed the acquisition of an additional 40.67% stake in Yapan Bio Pvt Ltd for ₹76 crore, taking its total holding in the Hyderabad-based company to 74%. With the completion of the transaction on August 18, Yapan Bio has become a subsidiary of Piramal Pharma. The company is a contract development and […]

CW Bureau · Aug 19, 2026

STARTUP/TECHNOLOGY Amgen To Set Up Science And Innovation Centre In Hyderabad

Hyderabad-based Amgen has announced plans to establish a new Science and Innovation Centre at Genome Valley in Hyderabad. The centre will become part of Amgen’s global Research and Development network, which comprises seven research laboratories. It will expand the company’s scientific and research capabilities in India. Centre to focus on advanced research The new facility […]

CW Bureau · Aug 12, 2026

GENERAL Amneal Pharma Completes Kashiv Bio Buy, Strengthens Biosimilars Platform

Amneal Pharmaceuticals Inc. has completed its acquisition of Kashiv BioSciences LLC, creating a fully integrated global biosimilars platform with capabilities spanning research, development, manufacturing and commercialisation. The acquisition brings together Kashiv’s biologics research, development and manufacturing capabilities with Amneal’s commercial scale, positioning biosimilars as a major long-term growth pillar for the company’s affordable medicines business. […]

CW Bureau · Aug 11, 2026

GENERAL Aurobindo Pharma Signs Licensing Agreement With MSD For HIV Drug

Aurobindo Pharma Ltd  has entered into a non-exclusive voluntary licensing agreement with MSD (the trade name of Merck & Co., Inc., Rahway, New Jersey, USA) to manufacture and supply a generic version of the investigational HIV prevention medicine, Alimatravir, in eligible low- and middle-income countries. Aurobindo Pharma is among a select group of global generic […]

CW Bureau · Jul 25, 2026

GENERAL US FDA Expands Glenmark RYALTRIS Approval To Children Above 6 Years

Glenmark Specialty S A has received approval from the US Food and Drug Administration (US FDA) to expand the use of its allergy treatment RYALTRIS nasal spray for pediatric patients aged 6 to less than 12 years suffering from Seasonal Allergic Rhinitis (SAR). The approval broadens the eligible patient population for the drug in the […]

CW Bureau · Jul 21, 2026

GENERAL Lupin Carves Out 2 Cancer Therapy Programmes Into New US Venture

Global pharmaceutical major Lupin Ltd has announced the strategic spin-out of two of its oncology programmes into Kaveri Therapeutics Inc., a US-based clinical-stage oncology company, in a move aimed at accelerating the global development of targeted cancer therapies. Independent platform for oncology development The spin-out will be executed through Lupin Inc., the company’s wholly owned […]

CW Bureau · Jul 21, 2026

GENERAL Sun Pharma Gets South Africa Nod For Generic Semaglutide Injection

Sun Pharmaceutical Industries Ltd (Sun Pharma) has received approval from the South African Health Products Regulatory Authority (SAHPRA) to manufacture and market a generic version of Semaglutide injection for the treatment of adults with inadequately controlled Type 2 diabetes mellitus. The approval marks South Africa as the second market after India where Sun Pharma has […]

CW Bureau · Jul 15, 2026

GENERAL Lupin Banks On Biosimilars, Specialty Medicines To Power Next Expansion

Lupin Ltd is stepping up its focus on biosimilars, specialty medicines, complex generics and artificial intelligence (AI) as it builds the next phase of its growth strategy, according to Chief Executive Officer Vinita Gupta and Managing Director Nilesh Gupta in a joint message to shareholders in the company’s Annual Report 2026. The leadership said years […]

CW Bureau · Jul 14, 2026

GENERAL Pfizer Focuses On Vaccines, Internal Medicine To Power Growth In India

Pfizer strengthened its growth momentum during the year In India through strong execution across its vaccines, internal medicine and hospital businesses, supported by new product launches, strategic partnerships and sustained market leadership across key therapeutic segments. In a message to shareholders in the company’s Annual Report 2026, Pfizer Ltd Managing Director Meenakshi Nevatia said the […]

CW Bureau · Jul 7, 2026